Liver Transplantation

  • Michael Sean Bleszynski
  • Peter T. W. Kim


The field of liver transplantation has changed since the MELD scoring system became the most widely used donor allocation tool. Due to the MELD-based allocation system, sicker patients with higher MELD scores are being transplanted. Persistent organ donor shortages remain a challenging issue, and as a result, the wait-list mortality is a persistent problem for most of the regions. This chapter focuses on deceased donor and live donor liver transplantation in patients with complications of portal hypertension. Special attention will also be placed on donor-recipient matching, perioperative management of transplant patients, and the impact of hepatic hemodynamics on transplantation.


Liver transplant Transplant futility MELD Portal vein thrombosis Portal flows Living donation 


  1. 1.
    Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124(1):91–6. PubMed PMID: 12512033. Epub 2003/01/04.PubMedCrossRefPubMedCentralGoogle Scholar
  2. 2.
    Freeman RB Jr, Wiesner RH, Harper A, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl. 2002;8(9):851–8. PubMed PMID: 12200791. Epub 2002/08/30.CrossRefGoogle Scholar
  3. 3.
    Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31(4):864–71. PubMed PMID: 10733541. Epub 2000/03/25.PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Merion RM, Wolfe RA, Dykstra DM, et al. Longitudinal assessment of mortality risk among candidates for liver transplantation. Liver Transpl. 2003;9(1):12–8. PubMed PMID: 12514767. Epub 2003/01/07.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Biggins SW, Bambha K. MELD-based liver allocation: who is underserved? Semin Liver Dis. 2006;26(3):211–20. PubMed PMID: 16850370. Epub 2006/07/20PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Bernardi M, Gitto S, Biselli M. The MELD score in patients awaiting liver transplant: strengths and weaknesses. J Hepatol. 2011;54(6):1297–306. PubMed PMID: 21145851. Epub 2010/12/15.PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Sharma P, Schaubel DE, Goodrich NP, Merion RM. Serum sodium and survival benefit of liver transplantation. Liver Transpl. 2015;21(3):308–13. PubMed PMID: 25504743. Pubmed Central PMCID: PMC4354811. Epub 2014/12/17.PubMedPubMedCentralCrossRefGoogle Scholar
  8. 8.
    Merion RM. When is a patient too well and when is a patient too sick for a liver transplant? Liver Transpl. 2004;10(10 Suppl 2):S69–73. PubMed PMID: 15382215. Epub 2004/09/24.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Farkas S, Hackl C, Schlitt HJ. Overview of the indications and contraindications for liver transplantation. Cold Spring Harb Perspect Med. 2014;4(5). PubMed PMID: 24789874. Pubmed Central PMCID: PMC3996378. Epub 2014/05/03.PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Schaubel DE, Guidinger MK, Biggins SW, et al. Survival benefit-based deceased-donor liver allocation. Am J Transplant. 2009;9(4 Pt 2):970–81. PubMed PMID: 19341419. Pubmed Central PMCID: PMC2895923. Epub 2009/04/04.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Merion RM, Schaubel DE, Dykstra DM, et al. The survival benefit of liver transplantation. Am J Transplant. 2005;5(2):307–13. PubMed PMID: 15643990. Epub 2005/01/13.PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Desai NM, Mange KC, Crawford MD, et al. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation. 2004;77(1):99–106. PubMed PMID: 14724442. Epub 2004/01/16.PubMedCrossRefPubMedCentralGoogle Scholar
  13. 13.
    Habib S, Berk B, Chang CC, et al. MELD and prediction of post-liver transplantation survival. Liver Transpl. 2006;12(3):440–7. PubMed PMID: 16498643. Epub 2006/02/25.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Murken DR, Peng AW, Aufhauser DD Jr, et al. Same policy, different impact: center-level effects of share 35 liver allocation. Liver Transpl. 2017;23(6):741–50. PubMed PMID: 28407441. Pubmed Central PMCID: PMC5494984. Epub 2017/04/14.PubMedPubMedCentralCrossRefGoogle Scholar
  15. 15.
    Karvellas CJ, Lescot T, Goldberg P, et al. Liver transplantation in the critically ill: a multicenter Canadian retrospective cohort study. Crit Care. 2013;17(1):R28. PubMed PMID: 23394270. Pubmed Central PMCID: PMC4056692. Epub 2013/02/12.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Aloia TA, Knight R, Gaber AO, et al. Analysis of liver transplant outcomes for united network for organ sharing recipients 60 years old or older identifies multiple model for end-stage liver disease-independent prognostic factors. Liver Transpl. 2010;16(8):950–9. PubMed PMID: 20589647. Epub 2010/07/01.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Asrani SK, Saracino G, O'Leary JG, et al. Recipient characteristics and morbidity and mortality after liver transplantation. J Hepatol. 2018;69(1):43–50. PubMed PMID: 29454069. Epub 2018/02/18.PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Gonzalez Martinez S, Molina Raya A, Becerra Massare A, et al. Liver transplantation in recipients with high model for end-stage liver disease score. Transplant Proc. 2018;50(2):595–7. PubMed PMID: 29579862. Epub 2018/03/28.PubMedCrossRefPubMedCentralGoogle Scholar
  19. 19.
    Cardoso FS, Karvellas CJ, Kneteman NM, et al. Postoperative resource utilization and survival among liver transplant recipients with model for end-stage liver disease score >/= 40: a retrospective cohort study. Can J Gastroenterol Hepatol. 2015;29(4):185–91. PubMed PMID: 25965438. Pubmed Central PMCID: PMC4444027. Epub 2015/05/13.PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Petrowsky H, Rana A, Kaldas FM, et al. Liver transplantation in highest acuity recipients: identifying factors to avoid futility. Ann Surg. 2014;259(6):1186–94. PubMed PMID: 24263317. Epub 2013/11/23.PubMedCrossRefPubMedCentralGoogle Scholar
  21. 21.
    Panchal HJ, Durinka JB, Patterson J, et al. Survival outcomes in liver transplant recipients with model for end-stage liver disease scores of 40 or higher: a decade-long experience. HPB (Oxford). 2015;17(12):1074–84. PubMed PMID: 26373873. Pubmed Central PMCID: PMC4644359. Epub 2015/09/17.CrossRefGoogle Scholar
  22. 22.
    Stratigopoulou P, Paul A, Hoyer DP, et al. High MELD score and extended operating time predict prolonged initial ICU stay after liver transplantation and influence the outcome. PLoS One. 2017;12(3):e0174173. PubMed PMID: 28319169. Pubmed Central PMCID: PMC5358862. Epub 2017/03/21.PubMedPubMedCentralCrossRefGoogle Scholar
  23. 23.
    Michard B, Artzner T, Lebas B, et al. Liver transplantation in critically ill patients: preoperative predictive factors of post-transplant mortality to avoid futility. Clin Transpl. 2017;31(12). PubMed PMID: 28895204. Epub 2017/09/13.CrossRefGoogle Scholar
  24. 24.
    Nekrasov V, Matsuoka L, Kaur N, et al. Improvement in the outcomes of MELD >/= 40 liver transplantation: an analysis of 207 consecutive transplants in a highly competitive DSA. Transplantation. 2017;101(10):2360–7. PubMed PMID: 28319564. Epub 2017/03/21.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Nekrasov V, Matsuoka L, Rauf M, et al. National outcomes of liver transplantation for model for end-stage liver disease score >/=40: the impact of share 35. Am J Transplant. 2016;16(10):2912–24. PubMed PMID: 27063579. Epub 2016/04/12.PubMedCrossRefPubMedCentralGoogle Scholar
  26. 26.
    Volk ML, Lok AS, Pelletier SJ, et al. Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation. Gastroenterology. 2008;135(5):1568–74. PubMed PMID: 19009713. Epub 2008/11/15.PubMedCrossRefPubMedCentralGoogle Scholar
  27. 27.
    Bahra M, Neuhaus P. Liver transplantation in the high MELD era: a fair chance for everyone? Langenbeck's Arch Surg. 2011;396(4):461–5. PubMed PMID: 21384189. Epub 2011/03/09CrossRefGoogle Scholar
  28. 28.
    Bonney GK, Aldersley MA, Asthana S, et al. Donor risk index and MELD interactions in predicting long-term graft survival: a single-centre experience. Transplantation. 2009;87(12):1858–63. PubMed PMID: 19543065. Epub 2009/06/23.PubMedCrossRefPubMedCentralGoogle Scholar
  29. 29.
    Goldberg DS, Levine M, Karp S, et al. Share 35 changes in center-level liver acceptance practices. Liver Transpl. 2017;23(5):604–13. PubMed PMID: 28240804. Pubmed Central PMCID: PMC5462450. Epub 2017/02/28.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Brody BA, Halevy A. Is futility a futile concept? J Med Philos. 1995;20(2):123–44. Scholar
  31. 31.
    Tomlinson T, Brody H. Ethics and communication in do-not-resuscitate orders. N Engl J Med. 1988;318(1):43–6. PubMed PMID: 3336383. Epub 1988/01/07.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Grant SB, Modi PK, Singer EA. Futility and the care of surgical patients: ethical dilemmas. World J Surg. 2014;38(7):1631–7. PubMed PMID: 24849199. Pubmed Central PMCID: PMC5176346. Epub 2014/05/23.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Schneiderman LJ, Jecker NS, Jonsen AR. Medical futility: its meaning and ethical implications. Ann Intern Med. 1990;112(12):949–54. PubMed PMID: 2187394. Epub 1990/06/15.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Rana A, Hardy MA, Halazun KJ, et al. Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant. 2008;8(12):2537–46. PubMed PMID: 18945283. Epub 2008/10/24.PubMedCrossRefPubMedCentralGoogle Scholar
  35. 35.
    Linecker M, Krones T, Berg T, et al. Potentially inappropriate liver transplantation in the era of the “sickest first” policy – a search for the upper limits. J Hepatol. 2018;68(4):798–813. Epub 2017 Nov 11.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Krowka MJ. Hepatopulmonary syndrome versus portopulmonary hypertension: distinctions and dilemmas. Hepatology. 1997;25(5):1282–4. PubMed PMID: 9141454. Epub 1997/05/01PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    Yang YY, Lin HC, Lee WC, et al. Portopulmonary hypertension: distinctive hemodynamic and clinical manifestations. J Gastroenterol. 2001;36(3):181–6. PubMed PMID: 11291881. Epub 2001/04/09.PubMedCrossRefPubMedCentralGoogle Scholar
  38. 38.
    Salgia RJ, Goodrich NP, Simpson H, et al. Outcomes of liver transplantation for porto-pulmonary hypertension in model for end-stage liver disease era. Dig Dis Sci. 2014;59(8):1976–82. PubMed PMID: 24557576. Pubmed Central PMCID: PMC4119507. Epub 2014/02/22.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Rodriguez-Roisin R, Krowka MJ, Herve P, et al. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J. 2004;24(5):861–80. PubMed PMID: 15516683. Epub 2004/11/02.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Krowka MJ, Frantz RP, McGoon MD, et al. Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): a study of 15 patients with moderate to severe portopulmonary hypertension. Hepatology. 1999;30(3):641–8. PubMed PMID: 10462369. Epub 1999/08/26.PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Krowka MJ, Plevak DJ, Findlay JY, et al. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl. 2000;6(4):443–50. PubMed PMID: 10915166. Epub 2000/07/29.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Krowka MJ, Miller DP, Barst RJ, et al. Portopulmonary hypertension: a report from the US-based REVEAL Registry. Chest. 2012;141(4):906–15. PubMed PMID: 21778257. Epub 2011/07/23.PubMedCrossRefPubMedCentralGoogle Scholar
  43. 43.
    Swanson KL, Wiesner RH, Nyberg SL, et al. Survival in portopulmonary hypertension: Mayo Clinic experience categorized by treatment subgroups. Am J Transplant. 2008;8(11):2445–53. PubMed PMID: 18782292. Epub 2008/09/11.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    Freeman RB Jr, Gish RG, Harper A, et al. Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula. Liver Transpl. 2006;12(12 Suppl 3):S128–36. PubMed PMID: 17123284. Epub 2006/11/24.PubMedCrossRefPubMedCentralGoogle Scholar
  45. 45.
    Krowka MJ, Wiesner RH, Heimbach JK. Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward. J Hepatol. 2013;59(2):367–74. PubMed PMID: 23557870. Epub 2013/04/06.PubMedCrossRefPubMedCentralGoogle Scholar
  46. 46.
    DuBrock HM, Goldberg DS, Sussman NL, et al. Predictors of waitlist mortality in portopulmonary hypertension. Transplantation. 2017;101(7):1609–15. PubMed PMID: 28207639. Pubmed Central PMCID: PMC5481480. Epub 2017/02/17.PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Rajaram P, Parekh A, Fisher M, et al. Comparison of post-liver transplantation outcomes in portopulmonary hypertension and pulmonary venous hypertension: a single-center experience. Transplant Proc. 2017;49(2):338–43. PubMed PMID: 28219595. Epub 2017/02/22.PubMedCrossRefPubMedCentralGoogle Scholar
  48. 48.
    Huang B, Shi Y, Liu J, et al. The early outcomes of candidates with portopulmonary hypertension after liver transplantation. BMC Gastroenterol. 2018;18(1):79. PubMed PMID: 29879915. Pubmed Central PMCID: PMC5992875. Epub 2018/06/09.PubMedPubMedCentralCrossRefGoogle Scholar
  49. 49.
    Sithamparanathan S, Nair A, Thirugnanasothy L, et al. Survival in portopulmonary hypertension: outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry. J Heart Lung Transplant. 2017;36(7):770–9. PubMed PMID: 28190786. Epub 2017/02/14.PubMedCrossRefPubMedCentralGoogle Scholar
  50. 50.
    Nadim MK, Sung RS, Davis CL, et al. Simultaneous liver-kidney transplantation summit: current state and future directions. Am J Transplant. 2012;12(11):2901–8. PubMed PMID: 22822723. Epub 2012/07/25.CrossRefGoogle Scholar
  51. 51.
    Eason JD, Gonwa TA, Davis CL, et al. Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK). Am J Transplant. 2008;8(11):2243–51. PubMed PMID: 18808402. Epub 2008/09/24.CrossRefGoogle Scholar
  52. 52.
    Formica RN, Aeder M, Boyle G, et al. Simultaneous liver-kidney allocation policy: a proposal to optimize appropriate utilization of scarce resources. Am J Transplant. 2016;16(3):758–66. PubMed PMID: 26603142. Epub 2015/11/26.CrossRefGoogle Scholar
  53. 53.
    Lunsford KE, Bodzin AS, Markovic D, et al. Avoiding futility in simultaneous liver-kidney transplantation: analysis of 331 consecutive patients listed for dual organ replacement. Ann Surg. 2017;265(5):1016–24. PubMed PMID: 27232249. Epub 2016/05/28.PubMedCrossRefPubMedCentralGoogle Scholar
  54. 54.
    Fong TL, Bunnapradist S, Jordan SC, et al. Analysis of the united network for organ sharing database comparing renal allografts and patient survival in combined liver-kidney transplantation with the contralateral allografts in kidney alone or kidney-pancreas transplantation. Transplantation. 2003;76(2):348–53. PubMed PMID: 12883191. Epub 2003/07/29.PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Simpson N, Cho YW, Cicciarelli JC, et al. Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: analysis of UNOS database. Transplantation. 2006;82(10):1298–303. PubMed PMID: 17130778. Epub 2006/11/30.PubMedCrossRefPubMedCentralGoogle Scholar
  56. 56.
    Puri V, Eason J. Simultaneous liver-kidney transplantation. Curr Transplant Rep. 2015;2(4):297–302. PubMed PMID: 26523249. Pubmed Central PMCID: PMC4623067. Epub 2015/11/03.PubMedPubMedCentralCrossRefGoogle Scholar
  57. 57.
    Davis CL, Feng S, Sung R, et al. Simultaneous liver-kidney transplantation: evaluation to decision making. Am J Transplant. 2007;7(7):1702–9. PubMed PMID: 17532752. Epub 2007/05/30.CrossRefGoogle Scholar
  58. 58.
    Ceulemans LJ, Strypstein S, Neyrinck A, et al. Combined liver-thoracic transplantation: single-center experience with introduction of the 'Liver-first' principle. Transpl Int. 2016;29(6):715–26. PubMed PMID: 27037837. Epub 2016/04/03.PubMedCrossRefPubMedCentralGoogle Scholar
  59. 59.
    Beal EW, Mumtaz K, Hayes D Jr, et al. Combined heart-liver transplantation: indications, outcomes and current experience. Transplant Rev (Orlando). 2016;30(4):261–8. PubMed PMID: 27527917. Pubmed Central PMCID: PMC5450025. Epub 2016/08/17.CrossRefGoogle Scholar
  60. 60.
    Cannon RM, Hughes MG, Jones CM, et al. A review of the United States experience with combined heart-liver transplantation. Transpl Int. 2012;25(12):1223–8. PubMed PMID: 22937819. Epub 2012/09/04.PubMedCrossRefPubMedCentralGoogle Scholar
  61. 61.
    Careddu L, Zanfi C, Pantaleo A, et al. Combined heart-liver transplantation: a single-center experience. Transpl Int. 2015;28(7):828–34. PubMed PMID: 25711771. Epub 2015/02/26.PubMedCrossRefPubMedCentralGoogle Scholar
  62. 62.
    Wong TW, Gandhi MJ, Daly RC, et al. Liver allograft provides Immunoprotection for the cardiac allograft in combined heart-liver transplantation. Am J Transplant. 2016;16(12):3522–31. PubMed PMID: 27184686. Epub 2016/05/18.PubMedCrossRefPubMedCentralGoogle Scholar
  63. 63.
    Weill D. Lung transplantation: indications and contraindications. J Thorac Dis. 2018;10(7):4574–87. PubMed PMID: 30174910. Pubmed Central PMCID: PMC6105990. Epub 2018/09/04.PubMedPubMedCentralCrossRefGoogle Scholar
  64. 64.
    Gadre S, Turowski J, Budev M. Overview of lung transplantation, heart-lung transplantation, liver-lung transplantation, and combined hematopoietic stem cell transplantation and lung transplantation. Clin Chest Med. 2017;38(4):623–40. PubMed PMID: 29128014. Epub 2017/11/13.PubMedCrossRefPubMedCentralGoogle Scholar
  65. 65.
    Pinderski LJ, Kirklin JK, McGiffin D, et al. Multi-organ transplantation: is there a protective effect against acute and chronic rejection? J Heart Lung Transplant. 2005;24(11):1828–33. PubMed PMID: 16297789. Epub 2005/11/22.PubMedCrossRefPubMedCentralGoogle Scholar
  66. 66.
    Rana A, Robles S, Russo MJ, et al. The combined organ effect: protection against rejection? Ann Surg. 2008;248(5):871–9. PubMed PMID: 18948817. Epub 2008/10/25.PubMedCrossRefPubMedCentralGoogle Scholar
  67. 67.
    Gottlieb J. Lung allocation. J Thorac Dis. 2017;9(8):2670–4. PubMed PMID: 28932574. Pubmed Central PMCID: PMC5594149. Epub 2017/09/22.PubMedPubMedCentralCrossRefGoogle Scholar
  68. 68.
    Wolf JH, Sulewski ME, Cassuto JR, et al. Simultaneous thoracic and abdominal transplantation: can we justify two organs for one recipient? Am J Transplant. 2013;13(7):1806–16. PubMed PMID: 23718142. Epub 2013/05/31.PubMedCrossRefPubMedCentralGoogle Scholar
  69. 69.
    Grannas G, Neipp M, Hoeper MM, et al. Indications for and outcomes after combined lung and liver transplantation: a single-center experience on 13 consecutive cases. Transplantation. 2008;85(4):524–31. PubMed PMID: 18347530. Epub 2008/03/19.PubMedCrossRefPubMedCentralGoogle Scholar
  70. 70.
    Yi SG, Burroughs SG, Loebe M, et al. Combined lung and liver transplantation: analysis of a single-center experience. Liver Transpl. 2014;20(1):46–53. PubMed PMID: 24136814. Epub 2013/10/19.PubMedCrossRefPubMedCentralGoogle Scholar
  71. 71.
    Scheiermann P, Czerner S, Kaspar M, et al. Combined lung and liver transplantation with extracorporeal membrane oxygenation instead of cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2016;30(2):437–42. PubMed PMID: 26432697. Epub 2015/10/04.PubMedCrossRefPubMedCentralGoogle Scholar
  72. 72.
    Butler P, Israel L, Nusbacher J, et al. Blood transfusion in liver transplantation. Transfusion. 1985;25(2):120–3. PubMed PMID: 3885484. Pubmed Central PMCID: PMC2967283. Epub 1985/03/01.PubMedPubMedCentralCrossRefGoogle Scholar
  73. 73.
    Massicotte L, Denault AY, Beaulieu D, et al. Transfusion rate for 500 consecutive liver transplantations: experience of one liver transplantation center. Transplantation. 2012;93(12):1276–81. PubMed PMID: 22617090. Epub 2012/05/24.PubMedCrossRefPubMedCentralGoogle Scholar
  74. 74.
    Schroeder RA, Kuo PC. Pro: low central venous pressure during liver transplantation – not too low. J Cardiothorac Vasc Anesth. 2008;22(2):311–4. PubMed PMID: 18375341. Epub 2008/04/01.PubMedCrossRefPubMedCentralGoogle Scholar
  75. 75.
    Massicotte L, Lenis S, Thibeault L, et al. Reduction of blood product transfusions during liver transplantation. Can J Anaesth. 2005;52(5):545–6. PubMed PMID: 15872137. Epub 2005/05/06.PubMedCrossRefPubMedCentralGoogle Scholar
  76. 76.
    Xia VW, Fond A, Du B. Ascites, but not hyponatremia, is associated with high intraoperative transfusion and vasopressor requirements during liver transplantation. Transplant Proc. 2006;38(5):1398–9. PubMed PMID: 16797315. Epub 2006/06/27.PubMedCrossRefPubMedCentralGoogle Scholar
  77. 77.
    Esmat Gamil M, Pirenne J, Van Malenstein H, et al. Risk factors for bleeding and clinical implications in patients undergoing liver transplantation. Transplant Proc. 2012;44(9):2857–60. PubMed PMID: 23146542. Epub 2012/11/14.PubMedCrossRefPubMedCentralGoogle Scholar
  78. 78.
    Massicotte L, Sassine MP, Lenis S, et al. Survival rate changes with transfusion of blood products during liver transplantation. Can J Anaesth. 2005;52(2):148–55. PubMed PMID: 15684254. Epub 2005/02/03.PubMedCrossRefPubMedCentralGoogle Scholar
  79. 79.
    Ramos E, Dalmau A, Sabate A, et al. Intraoperative red blood cell transfusion in liver transplantation: influence on patient outcome, prediction of requirements, and measures to reduce them. Liver Transpl. 2003;9(12):1320–7. PubMed PMID: 14625833. Epub 2003/11/20.PubMedCrossRefPubMedCentralGoogle Scholar
  80. 80.
    Boin IF, Leonardi MI, Luzo AC, et al. Intraoperative massive transfusion decreases survival after liver transplantation. Transplant Proc. 2008;40(3):789–91. PubMed PMID: 18455018. Epub 2008/05/06.PubMedCrossRefPubMedCentralGoogle Scholar
  81. 81.
    Massicotte L, Sassine MP, Lenis S, Roy A. Transfusion predictors in liver transplant. Anesth Analg. 2004;98(5):1245–51, table of contents. PubMed PMID: 15105195. Epub 2004/04/24.PubMedCrossRefPubMedCentralGoogle Scholar
  82. 82.
    McCluskey SA, Karkouti K, Wijeysundera DN, et al. Derivation of a risk index for the prediction of massive blood transfusion in liver transplantation. Liver Transpl. 2006;12(11):1584–93. PubMed PMID: 16952177. Epub 2006/09/05.PubMedCrossRefPubMedCentralGoogle Scholar
  83. 83.
    Saracoglu A, Saracoglu KT. Coagulopathy during liver transplantation. J Anaesthesiol Clin Pharmacol. 2018;34(3):289–95. PubMed PMID: 30386008. Pubmed Central PMCID: PMC6194832. Epub 2018/11/06.PubMedPubMedCentralGoogle Scholar
  84. 84.
    Violi F, Basili S, Raparelli V, et al. Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction? J Hepatol. 2011;55(6):1415–27. PubMed PMID: 21718668. Epub 2011/07/02.PubMedCrossRefPubMedCentralGoogle Scholar
  85. 85.
    Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood. 2010;116(6):878–85. PubMed PMID: 20400681. Epub 2010/04/20.PubMedPubMedCentralCrossRefGoogle Scholar
  86. 86.
    Tripodi A, Salerno F, Chantarangkul V, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology. 2005;41(3):553–8. PubMed PMID: 15726661. Epub 2005/02/24.PubMedCrossRefPubMedCentralGoogle Scholar
  87. 87.
    Caldwell SH, Hoffman M, Lisman T, et al. Coagulation disorders and hemostasis in liver disease: pathophysiology and critical assessment of current management. Hepatology. 2006;44(4):1039–46. PubMed PMID: 17006940. Epub 2006/09/29.PubMedCrossRefPubMedCentralGoogle Scholar
  88. 88.
    Cleland S, Corredor C, Ye JJ, et al. Massive haemorrhage in liver transplantation: consequences, prediction and management. World J Transplant. 2016;6(2):291–305. PubMed PMID: 27358774. Pubmed Central PMCID: PMC4919733. Epub 2016/07/01.PubMedPubMedCentralCrossRefGoogle Scholar
  89. 89.
    Calne RY. Surgical aspects of clinical liver transplantation in 14 cases. Br J Surg. 1969;56(10):729–36. PubMed PMID: 4899842. Epub 1969/10/01.PubMedCrossRefPubMedCentralGoogle Scholar
  90. 90.
    Steib A, Freys G, Lehmann C, et al. Intraoperative blood losses and transfusion requirements during adult liver transplantation remain difficult to predict. Can J Anaesth. 2001;48(11):1075–9. PubMed PMID: 11744582. Epub 2001/12/18.PubMedCrossRefPubMedCentralGoogle Scholar
  91. 91.
    Reyle-Hahn M, Rossaint R. Coagulation techniques are not important in directing blood product transfusion during liver transplantation. Liver Transpl Surg. 1997;3(6):659–63; discussion 63–5. PubMed PMID: 9404973. Epub 1997/12/24.PubMedCrossRefPubMedCentralGoogle Scholar
  92. 92.
    Adelmann D, Kronish K, Ramsay MA. Anesthesia for liver transplantation. Anesthesiol Clin. 2017;35(3):491–508. PubMed PMID: 28784222. Epub 2017/08/09.PubMedCrossRefPubMedCentralGoogle Scholar
  93. 93.
    Lisman T, Porte RJ. Platelet function in patients with cirrhosis. J Hepatol. 2012;56(4):993–4; author reply 4–5. PubMed PMID: 22424439. Epub 2012/03/20.PubMedCrossRefPubMedCentralGoogle Scholar
  94. 94.
    Donohue CI, Mallett SV. Reducing transfusion requirements in liver transplantation. World J Transplant. 2015;5(4):165–82. PubMed PMID: 26722645. Pubmed Central PMCID: PMC4689928. Epub 2016/01/02.PubMedPubMedCentralCrossRefGoogle Scholar
  95. 95.
    Tzakis A, Todo S, Starzl TE. Orthotopic liver transplantation with preservation of the inferior vena cava. Ann Surg. 1989;210(5):649–52. PubMed PMID: 2818033. Pubmed Central PMCID: PMC1357802. Epub 1989/11/01.PubMedPubMedCentralCrossRefGoogle Scholar
  96. 96.
    Belghiti J, Panis Y, Sauvanet A, et al. A new technique of side to side caval anastomosis during orthotopic hepatic transplantation without inferior vena caval occlusion. Surg Gynecol Obstet. 1992;175(3):270–2. PubMed PMID: 1514163. Epub 1992/09/01.PubMedPubMedCentralGoogle Scholar
  97. 97.
    Schmitz V, Schoening W, Jelkmann I, et al. Different cava reconstruction techniques in liver transplantation: piggyback versus cava resection. Hepatobiliary Pancreat Dis Int. 2014;13(3):242–9. PubMed PMID: 24919606. Epub 2014/06/13.PubMedCrossRefPubMedCentralGoogle Scholar
  98. 98.
    Moreno-Gonzalez E, Meneu-Diaz JG, Fundora Y, et al. Advantages of the piggy back technique on intraoperative transfusion, fluid compsumption, and vasoactive drugs requirements in liver transplantation: a comparative study. Transplant Proc. 2003;35(5):1918–9. PubMed PMID: 12962848. Epub 2003/09/10.PubMedCrossRefPubMedCentralGoogle Scholar
  99. 99.
    Navarro F, Le Moine MC, Fabre JM, et al. Specific vascular complications of orthotopic liver transplantation with preservation of the retrohepatic vena cava: review of 1361 cases. Transplantation. 1999;68(5):646–50. PubMed PMID: 10507483. Epub 1999/10/03.PubMedCrossRefPubMedCentralGoogle Scholar
  100. 100.
    Forkin KT, Colquhoun DA, Nemergut EC, Huffmyer JL. The coagulation profile of end-stage liver disease and considerations for intraoperative management. Anesth Analg. 2018;126(1):46–61. PubMed PMID: 28795966. Epub 2017/08/11.PubMedCrossRefPubMedCentralGoogle Scholar
  101. 101.
    Thakrar SV, Melikian CN. Anaesthesia for liver transplantation. Br J Hosp Med (Lond). 2017;78(5):260–5. PubMed PMID: 28489450. Epub 2017/05/11.CrossRefGoogle Scholar
  102. 102.
    Hilmi I, Horton CN, Planinsic RM, et al. The impact of postreperfusion syndrome on short-term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation. Liver Transpl. 2008;14(4):504–8. PubMed PMID: 18383079. Epub 2008/04/03.PubMedCrossRefPubMedCentralGoogle Scholar
  103. 103.
    Siniscalchi A, Gamberini L, Laici C, et al. Post reperfusion syndrome during liver transplantation: from pathophysiology to therapy and preventive strategies. World J Gastroenterol. 2016;22(4):1551–69. PubMed PMID: 26819522. Pubmed Central PMCID: PMC4721988. Epub 2016/01/29.PubMedPubMedCentralCrossRefGoogle Scholar
  104. 104.
    Brems JJ, Millis JM, Hiatt JR, et al. Hepatic artery reconstruction during liver transplantation. Transplantation. 1989;47(2):403–6. PubMed PMID: 2645728. Epub 1989/02/01.PubMedCrossRefPubMedCentralGoogle Scholar
  105. 105.
    Mallett SV. Clinical utility of viscoelastic tests of coagulation (TEG/ROTEM) in patients with liver disease and during liver transplantation. Semin Thromb Hemost. 2015;41(5):527–37. PubMed PMID: 26049072. Epub 2015/06/07.PubMedCrossRefPubMedCentralGoogle Scholar
  106. 106.
    Hawkins RB, Raymond SL, Hartjes T, et al. Review: the perioperative use of thromboelastography for liver transplant patients. Transplant Proc. 2018;50(10):3552–8. PubMed PMID: 30577236. Epub 2018/12/24.PubMedCrossRefPubMedCentralGoogle Scholar
  107. 107.
    Ganter MT, Hofer CK. Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg. 2008;106(5):1366–75. PubMed PMID: 18420846. Epub 2008/04/19.PubMedCrossRefPubMedCentralGoogle Scholar
  108. 108.
    Lawson PJ, Moore HB, Moore EE, et al. Preoperative thrombelastography maximum amplitude predicts massive transfusion in liver transplantation. J Surg Res. 2017;220:171–5. PubMed PMID: 29180179. Pubmed Central PMCID: PMC5726438. Epub 2017/11/29.PubMedPubMedCentralCrossRefGoogle Scholar
  109. 109.
    Tafur LA, Taura P, Blasi A, et al. Rotation thromboelastometry velocity curve predicts blood loss during liver transplantation. Br J Anaesth. 2016;117(6):741–8. PubMed PMID: 27956672. Epub 2016/12/14.PubMedCrossRefPubMedCentralGoogle Scholar
  110. 110.
    Wang SC, Shieh JF, Chang KY, et al. Thromboelastography-guided transfusion decreases intraoperative blood transfusion during orthotopic liver transplantation: randomized clinical trial. Transplant Proc. 2010;42(7):2590–3. PubMed PMID: 20832550. Epub 2010/09/14.PubMedCrossRefPubMedCentralGoogle Scholar
  111. 111.
    Zamper RPC, Amorim TC, Queiroz VNF, et al. Association between viscoelastic tests-guided therapy with synthetic factor concentrates and allogenic blood transfusion in liver transplantation: a before-after study. BMC Anesthesiol. 2018;18(1):198. PubMed PMID: 30579327. Pubmed Central PMCID: PMC6303918. Epub 2018/12/24.PubMedPubMedCentralCrossRefGoogle Scholar
  112. 112.
    Molenaar IQ, Warnaar N, Groen H, et al. Efficacy and safety of antifibrinolytic drugs in liver transplantation: a systematic review and meta-analysis. Am J Transplant. 2007;7(1):185–94. PubMed PMID: 17227567. Epub 2007/01/18.PubMedCrossRefPubMedCentralGoogle Scholar
  113. 113.
    Kozek-Langenecker SA, Afshari A, Albaladejo P, et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2013;30(6):270–382. PubMed PMID: 23656742. Epub 2013/05/10.PubMedCrossRefPubMedCentralGoogle Scholar
  114. 114.
    Trzebicki J, Flakiewicz E, Kosieradzki M, et al. The use of thromboelastometry in the assessment of hemostasis during orthotopic liver transplantation reduces the demand for blood products. Ann Transplant. 2010;15(3):19–24. PubMed PMID: 20877262. Epub 2010/09/30.PubMedPubMedCentralGoogle Scholar
  115. 115.
    Henderson JM, Mackay GJ, Hooks M, et al. High cardiac output of advanced liver disease persists after orthotopic liver transplantation. Hepatology. 1992;15(2):258–62. PubMed PMID: 1735528. Epub 1992/02/01.PubMedCrossRefPubMedCentralGoogle Scholar
  116. 116.
    Hori T, Ogura Y, Onishi Y, et al. Systemic hemodynamics in advanced cirrhosis: concerns during perioperative period of liver transplantation. World J Hepatol. 2016;8(25):1047–60. PubMed PMID: 27660671. Pubmed Central PMCID: PMC5026996. Epub 2016/09/24.PubMedPubMedCentralCrossRefGoogle Scholar
  117. 117.
    Piardi T, Lhuaire M, Bruno O, et al. Vascular complications following liver transplantation: a literature review of advances in 2015. World J Hepatol. 2016;8(1):36–57. PubMed PMID: 26783420. Pubmed Central PMCID: PMC4705452. Epub 2016/01/20.PubMedPubMedCentralCrossRefGoogle Scholar
  118. 118.
    Heaton ND. Hepatic artery thrombosis: conservative management or retransplantation? Liver Transpl. 2013;19(Suppl 2):S14–6. PubMed PMID: 24019107. Epub 2013/09/11.PubMedCrossRefPubMedCentralGoogle Scholar
  119. 119.
    Singhal A, Stokes K, Sebastian A, et al. Endovascular treatment of hepatic artery thrombosis following liver transplantation. Transpl Int. 2010;23(3):245–56. PubMed PMID: 20030796. Epub 2009/12/25.PubMedCrossRefPubMedCentralGoogle Scholar
  120. 120.
    Buchholz BM, Khan S, David MD, et al. Retransplantation in late hepatic artery thrombosis: graft access and transplant outcome. Transplant Direct. 2017;3(8):e186. PubMed PMID: 28795138. Pubmed Central PMCID: PMC5540624. Epub 2017/08/11.PubMedPubMedCentralCrossRefGoogle Scholar
  121. 121.
    Bekker J, Ploem S, de Jong KP. Early hepatic artery thrombosis after liver transplantation: a systematic review of the incidence, outcome and risk factors. Am J Transplant. 2009;9(4):746–57. PubMed PMID: 19298450. Epub 2009/03/21.PubMedCrossRefPubMedCentralGoogle Scholar
  122. 122.
    Gunsar F, Rolando N, Pastacaldi S, et al. Late hepatic artery thrombosis after orthotopic liver transplantation. Liver Transpl. 2003;9(6):605–11. PubMed PMID: 12783403. Epub 2003/06/05.PubMedCrossRefPubMedCentralGoogle Scholar
  123. 123.
    Dani G, Sun MR, Bennett AE. Imaging of liver transplant and its complications. Semin Ultrasound CT MR. 2013;34(4):365–77. PubMed PMID: 23895908. Epub 2013/07/31.PubMedCrossRefPubMedCentralGoogle Scholar
  124. 124.
    Herrero A, Souche R, Joly E, et al. Early hepatic artery thrombosis after liver transplantation: what is the impact of the arterial reconstruction type? World J Surg. 2017;41(8):2101–10. PubMed PMID: 28324141. Epub 2017/03/23.PubMedCrossRefPubMedCentralGoogle Scholar
  125. 125.
    Chatzizacharias NA, Aly M, Praseedom RK. The role of arterial conduits for revascularisation in adult orthotopic liver transplantation. Transplant Rev (Orlando). 2017;31(2):121–6. PubMed PMID: 27884502. Epub 2016/11/26.CrossRefGoogle Scholar
  126. 126.
    Schroering JR, Kubal CA, Fridell JA, et al. Impact of variant donor hepatic arterial anatomy on clinical graft outcomes in liver transplantation. Liver Transpl. 2018;24(10):1481–4. PubMed PMID: 30054968. Pubmed Central PMCID: PMC6298596. Epub 2018/07/29.PubMedPubMedCentralCrossRefGoogle Scholar
  127. 127.
    Sheiner PA, Varma CV, Guarrera JV, et al. Selective revascularization of hepatic artery thromboses after liver transplantation improves patient and graft survival. Transplantation. 1997;64(9):1295–9. PubMed PMID: 9371671. Epub 1997/11/26.PubMedCrossRefPubMedCentralGoogle Scholar
  128. 128.
    Crossin JD, Muradali D, Wilson SR. US of liver transplants: normal and abnormal. Radiographics. 2003;23(5):1093–114. PubMed PMID: 12975502. Epub 2003/09/17.PubMedCrossRefPubMedCentralGoogle Scholar
  129. 129.
    Baheti AD, Sanyal R, Heller MT, Bhargava P. Surgical techniques and imaging complications of liver transplant. Radiol Clin N Am. 2016;54(2):199–215. PubMed PMID: 26896220. Epub 2016/02/21.PubMedCrossRefPubMedCentralGoogle Scholar
  130. 130.
    Marin-Gomez LM, Bernal-Bellido C, Alamo-Martinez JM, et al. Intraoperative hepatic artery blood flow predicts early hepatic artery thrombosis after liver transplantation. Transplant Proc. 2012;44(7):2078–81. PubMed PMID: 22974916. Epub 2012/09/15.PubMedCrossRefPubMedCentralGoogle Scholar
  131. 131.
    Stange BJ, Glanemann M, Nuessler NC, et al. Hepatic artery thrombosis after adult liver transplantation. Liver Transpl. 2003;9(6):612–20. PubMed PMID: 12783404. Epub 2003/06/05.PubMedCrossRefPubMedCentralGoogle Scholar
  132. 132.
    Scarinci A, Sainz-Barriga M, Berrevoet F, et al. Early arterial revascularization after hepatic artery thrombosis may avoid graft loss and improve outcomes in adult liver transplantation. Transplant Proc. 2010;42(10):4403–8. PubMed PMID: 21168708. Epub 2010/12/21.PubMedCrossRefPubMedCentralGoogle Scholar
  133. 133.
    Chen J, Weinstein J, Black S, et al. Surgical and endovascular treatment of hepatic arterial complications following liver transplant. Clin Transpl. 2014;28(12):1305–12. PubMed PMID: 25091402. Epub 2014/08/06.CrossRefGoogle Scholar
  134. 134.
    Rostambeigi N, Hunter D, Duval S, et al. Stent placement versus angioplasty for hepatic artery stenosis after liver transplant: a meta-analysis of case series. Eur Radiol. 2013;23(5):1323–34. PubMed PMID: 23239061. Epub 2012/12/15.PubMedCrossRefGoogle Scholar
  135. 135.
    Pitchaimuthu M, Roll GR, Zia Z, et al. Long-term follow-up after endovascular treatment of hepatic venous outflow obstruction following liver transplantation. Transpl Int. 2016;29(10):1106–16. PubMed PMID: 27371935. Epub 2016/07/03.PubMedCrossRefGoogle Scholar
  136. 136.
    Umehara M, Narumi S, Sugai M, et al. Hepatic venous outflow obstruction in living donor liver transplantation: balloon angioplasty or stent placement? Transplant Proc. 2012;44(3):769–71. PubMed PMID: 22483491. Epub 2012/04/10.PubMedCrossRefGoogle Scholar
  137. 137.
    Arudchelvam J, Bartlett A, McCall J, et al. Hepatic venous outflow obstruction in piggyback liver transplantation: single centre experience. ANZ J Surg. 2017;87(3):182–5. PubMed PMID: 26471387. Epub 2015/10/17.PubMedCrossRefGoogle Scholar
  138. 138.
    Khorsandi SE, Athale A, Vilca-Melendez H, et al. Presentation, diagnosis, and management of early hepatic venous outflow complications in whole cadaveric liver transplant. Liver Transpl. 2015;21(7):914–21. PubMed PMID: 25907399. Epub 2015/04/25.PubMedCrossRefPubMedCentralGoogle Scholar
  139. 139.
    Fujimori M, Yamakado K, Takaki H, et al. Long-term results of stent placement in patients with outflow block after living-donor-liver transplantation. Cardiovasc Intervent Radiol. 2016;39(4):566–74. PubMed PMID: 26464222. Epub 2015/10/16.PubMedCrossRefGoogle Scholar
  140. 140.
    Wang SL, Sze DY, Busque S, et al. Treatment of hepatic venous outflow obstruction after piggyback liver transplantation. Radiology. 2005;236(1):352–9. PubMed PMID: 15955856. Epub 2005/06/16.PubMedCrossRefGoogle Scholar
  141. 141.
    Kim KS, Lee JS, Choi GS, et al. Long-term outcomes after stent insertion in patients with early and late hepatic vein outflow obstruction after living donor liver transplantation. Ann Surg Treat Res. 2018;95(6):333–9. PubMed PMID: 30505825. Pubmed Central PMCID: PMC6255746. Epub 2018/12/07.PubMedPubMedCentralCrossRefGoogle Scholar
  142. 142.
    Kochhar G, Parungao JM, Hanouneh IA, Parsi MA. Biliary complications following liver transplantation. World J Gastroenterol. 2013;19(19):2841–6. PubMed PMID: 23704818. Pubmed Central PMCID: PMC3660810. Epub 2013/05/25.PubMedPubMedCentralCrossRefGoogle Scholar
  143. 143.
    Axelrod DA, Dzebisashvilli N, Lentine KL, et al. National assessment of early biliary complications after liver transplantation: economic implications. Transplantation. 2014;98(11):1226–35. PubMed PMID: 25119126. Epub 2014/08/15.PubMedCrossRefPubMedCentralGoogle Scholar
  144. 144.
    O'Neill S, Roebuck A, Khoo E, et al. A meta-analysis and meta-regression of outcomes including biliary complications in donation after cardiac death liver transplantation. Transpl Int. 2014;27(11):1159–74. PubMed PMID: 25052036. Epub 2014/07/24.PubMedCrossRefPubMedCentralGoogle Scholar
  145. 145.
    Seehofer D, Eurich D, Veltzke-Schlieker W, Neuhaus P. Biliary complications after liver transplantation: old problems and new challenges. Am J Transplant. 2013;13(2):253–65. PubMed PMID: 23331505. Epub 2013/01/22.PubMedCrossRefPubMedCentralGoogle Scholar
  146. 146.
    Kim WR, Lake JR, Smith JM, et al. OPTN/SRTR 2013 annual data report: liver. Am J Transplant. 2015;15(Suppl 2):1–28. PubMed PMID: 25626341. Epub 2015/01/30.PubMedCrossRefPubMedCentralGoogle Scholar
  147. 147.
    Dutkowski P, Oberkofler CE, Slankamenac K, et al. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era. Ann Surg. 2011;254(5):745–53; discussion 53. PubMed PMID: 22042468. Epub 2011/11/02.PubMedCrossRefPubMedCentralGoogle Scholar
  148. 148.
    Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006;6(4):783–90. PubMed PMID: 16539636. Epub 2006/03/17.PubMedCrossRefPubMedCentralGoogle Scholar
  149. 149.
    Halldorson JB, Bakthavatsalam R, Fix O, et al. D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant. 2009;9(2):318–26. PubMed PMID: 19120079. Epub 2009/01/06.PubMedCrossRefPubMedCentralGoogle Scholar
  150. 150.
    Northup PG, Berg CL. Preoperative delta-MELD score does not independently predict mortality after liver transplantation. Am J Transplant. 2004;4(10):1643–9. PubMed PMID: 15367219. Epub 2004/09/16.PubMedCrossRefPubMedCentralGoogle Scholar
  151. 151.
    Briceno J, Ciria R, de la Mata M. Donor-recipient matching: myths and realities. J Hepatol. 2013;58(4):811–20. PubMed PMID: 23104164. Epub 2012/10/30.PubMedCrossRefPubMedCentralGoogle Scholar
  152. 152.
    Buescher N, Seehofer D, Helbig M, et al. Evaluating twenty-years of follow-up after orthotopic liver transplantation, best practice for donor-recipient matching: what can we learn from the past era? World J Transplant. 2016;6(3):599–607. PubMed PMID: 27683639. Pubmed Central PMCID: PMC5036130. Epub 2016/09/30.PubMedPubMedCentralCrossRefGoogle Scholar
  153. 153.
    Rauchfuss F, Zidan A, Scheuerlein H, et al. Waiting time, not donor-risk-index, is a major determinant for beneficial outcome after liver transplantation in high-MELD patients. Ann Transplant. 2013;18:243–7. PubMed PMID: 23792527. Epub 2013/06/26.PubMedCrossRefGoogle Scholar
  154. 154.
    Englesbe MJ, Kubus J, Muhammad W, et al. Portal vein thrombosis and survival in patients with cirrhosis. Liver Transpl. 2010;16(1):83–90. PubMed PMID: 20035521. Epub 2009/12/26.PubMedCrossRefPubMedCentralGoogle Scholar
  155. 155.
    Paskonis M, Jurgaitis J, Mehrabi A, et al. Surgical strategies for liver transplantation in the case of portal vein thrombosis--current role of cavoportal hemitransposition and renoportal anastomosis. Clin Transpl. 2006;20(5):551–62. PubMed PMID: 16968480. Epub 2006/09/14.CrossRefGoogle Scholar
  156. 156.
    Ögren M, Bergqvist D, Björck M et al. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population studybased on 23,796 consecutive autopsies. World J Gastroenterol. 2006 Apr 7;12(13):2115–9. Scholar
  157. 157.
    Ögren M, Bergqvist D, Björck M, et al. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population studybased on 23,796 consecutive autopsies. World J Gastroenterol. 2006;12(13):2115–9. Scholar
  158. 158.
    Amitrano L, Brancaccio V, Guardascione MA, et al. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology. 2000;31(2):345–8. PubMed PMID: 10655256. Epub 2000/02/03.PubMedCrossRefGoogle Scholar
  159. 159.
    Chamarthy MR, Anderson ME, Pillai AK, Kalva SP. Thrombolysis and Transjugular intrahepatic Portosystemic shunt creation for acute and subacute portal vein thrombosis. Tech Vasc Interv Radiol. 2016;19(1):42–51. PubMed PMID: 26997088. Epub 2016/03/22.PubMedCrossRefGoogle Scholar
  160. 160.
    Ponziani FR. Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. World J Gastroenterol. 2010;16(2):143–55.PubMedPubMedCentralCrossRefGoogle Scholar
  161. 161.
    Valla DC, Condat B, Lebrec D. Spectrum of portal vein thrombosis in the west. J Gastroenterol Hepatol. 2002;17(Suppl 3):S224–7. PubMed PMID: 12472940. Epub 2002/12/11.PubMedCrossRefPubMedCentralGoogle Scholar
  162. 162.
    Chawla Y, Duseja A, Dhiman RK. Review article: the modern management of portal vein thrombosis. Aliment Pharmacol Ther. 2009;30(9):881–94. PubMed PMID: 19678814. Epub 2009/08/15.PubMedCrossRefGoogle Scholar
  163. 163.
    Delgado MG, Seijo S, Yepes I, et al. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin Gastroenterol Hepatol. 2012;10(7):776–83. PubMed PMID: 22289875. Epub 2012/02/01.PubMedPubMedCentralCrossRefGoogle Scholar
  164. 164.
    Villa E, Camma C, Marietta M, et al. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology. 2012;143(5):1253–60 e4. PubMed PMID: 22819864. Epub 2012/07/24.PubMedPubMedCentralCrossRefGoogle Scholar
  165. 165.
    Thornburg B, Desai K, Hickey R, et al. Portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: technical considerations. Tech Vasc Interv Radiol. 2016;19(1):52–60. PubMed PMID: 26997089. Epub 2016/03/22.PubMedCrossRefGoogle Scholar
  166. 166.
    Luca A, Miraglia R, Caruso S, et al. Short- and long-term effects of the transjugular intrahepatic portosystemic shunt on portal vein thrombosis in patients with cirrhosis. Gut. 2011;60(6):846–52. PubMed PMID: 21357252. Epub 2011/03/02.PubMedCrossRefGoogle Scholar
  167. 167.
    Manzanet G, Sanjuan F, Orbis P, et al. Liver transplantation in patients with portal vein thrombosis. Liver Transpl. 2001;7(2):125–31. PubMed PMID: 11172396. Epub 2001/02/15.PubMedCrossRefGoogle Scholar
  168. 168.
    Shaked A, Busuttil RW. Liver transplantation in patients with portal vein thrombosis and central portacaval shunts. Ann Surg. 1991;214(6):696–702. PubMed PMID: 1741649. Pubmed Central PMCID: PMC1358494. Epub 1991/12/01.PubMedPubMedCentralCrossRefGoogle Scholar
  169. 169.
    Englesbe MJ, Schaubel DE, Cai S, et al. Portal vein thrombosis and liver transplant survival benefit. Liver Transpl. 2010;16(8):999–1005. PubMed PMID: 20677291. Pubmed Central PMCID: PMC2915450. Epub 2010/08/03.PubMedPubMedCentralCrossRefGoogle Scholar
  170. 170.
    Doenecke A, Tsui TY, Zuelke C, et al. Pre-existent portal vein thrombosis in liver transplantation: influence of pre-operative disease severity. Clin Transpl. 2010;24(1):48–55. PubMed PMID: 19236435. Epub 2009/02/25.CrossRefGoogle Scholar
  171. 171.
    Molmenti EP, Roodhouse TW, Molmenti H, et al. Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation. Ann Surg. 2002;235(2):292–6. PubMed PMID: 11807371. Pubmed Central PMCID: PMC1422428. Epub 2002/01/25.PubMedPubMedCentralCrossRefGoogle Scholar
  172. 172.
    Gimeno FA, Calvo J, Loinaz C, et al. Comparative analysis of the results of orthotopic liver transplantation in patients with and without portal vein thrombosis. Transplant Proc. 2005;37(9):3899–903. PubMed PMID: 16386578. Epub 2006/01/03.PubMedCrossRefGoogle Scholar
  173. 173.
    Llado L, Fabregat J, Castellote J, et al. Management of portal vein thrombosis in liver transplantation: influence on morbidity and mortality. Clin Transpl. 2007;21(6):716–21. PubMed PMID: 17988264. Epub 2007/11/09.Google Scholar
  174. 174.
    Yerdel MA, Gunson B, Mirza D, et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation. 2000;69(9):1873–81. PubMed PMID: 10830225. Epub 2000/06/01.PubMedCrossRefPubMedCentralGoogle Scholar
  175. 175.
    Pan C, Shi Y, Zhang JJ, et al. Single-center experience of 253 portal vein thrombosis patients undergoing liver transplantation in China. Transplant Proc. 2009;41(9):3761–5. PubMed PMID: 19917382. Epub 2009/11/18.PubMedCrossRefPubMedCentralGoogle Scholar
  176. 176.
    Jia YP, Lu Q, Gong S, et al. Postoperative complications in patients with portal vein thrombosis after liver transplantation: evaluation with Doppler ultrasonography. World J Gastroenterol. 2007;13(34):4636–40. PubMed PMID: 17729421. Pubmed Central PMCID: PMC4611842. Epub 2007/08/31.PubMedPubMedCentralCrossRefGoogle Scholar
  177. 177.
    Quintini C, Spaggiari M, Hashimoto K, et al. Safety and effectiveness of renoportal bypass in patients with complete portal vein thrombosis: an analysis of 10 patients. Liver Transpl. 2015;21(3):344–52. PubMed PMID: 25420619. Epub 2014/11/26.PubMedCrossRefPubMedCentralGoogle Scholar
  178. 178.
    Hibi T, Nishida S, Levi DM, et al. When and why portal vein thrombosis matters in liver transplantation: a critical audit of 174 cases. Ann Surg. 2014;259(4):760–6. PubMed PMID: 24299686. Epub 2013/12/05.PubMedCrossRefPubMedCentralGoogle Scholar
  179. 179.
    Woo DH, Laberge JM, Gordon RL, et al. Management of portal venous complications after liver transplantation. Tech Vasc Interv Radiol. 2007;10(3):233–9. PubMed PMID: 18086428. Epub 2007/12/19.PubMedCrossRefPubMedCentralGoogle Scholar
  180. 180.
    Funaki B, Rosenblum JD, Leef JA, et al. Portal vein stenosis in children with segmental liver transplants: treatment with percutaneous transhepatic venoplasty. AJR Am J Roentgenol. 1995;165(1):161–5. PubMed PMID: 7785578. Epub 1995/07/01.PubMedCrossRefPubMedCentralGoogle Scholar
  181. 181.
    Shibata T, Itoh K, Kubo T, et al. Percutaneous transhepatic balloon dilation of portal venous stenosis in patients with living donor liver transplantation. Radiology. 2005;235(3):1078–83. PubMed PMID: 15845790. Epub 2005/04/23.PubMedCrossRefPubMedCentralGoogle Scholar
  182. 182.
    Lautt WW. Regulatory processes interacting to maintain hepatic blood flow constancy: vascular compliance, hepatic arterial buffer response, hepatorenal reflex, liver regeneration, escape from vasoconstriction. Hepatol Res. 2007;37(11):891–903. PubMed PMID: 17854463. Pubmed Central PMCID: PMC2981600. Epub 2007/09/15.PubMedPubMedCentralCrossRefGoogle Scholar
  183. 183.
    Wakim KG. Physiology of the liver. Am J Med. 1954;16(2):256–71. PubMed PMID: 13124358. Epub 1954/02/01.PubMedCrossRefPubMedCentralGoogle Scholar
  184. 184.
    Eipel C, Abshagen K, Vollmar B. Regulation of hepatic blood flow: the hepatic arterial buffer response revisited. World J Gastroenterol. 2010;16(48):6046–57. PubMed PMID: 21182219. Pubmed Central PMCID: PMC3012579. Epub 2010/12/25.PubMedPubMedCentralCrossRefGoogle Scholar
  185. 185.
    Feng AC, Fan HL, Chen TW, Hsieh CB. Hepatic hemodynamic changes during liver transplantation: a review. World J Gastroenterol. 2014;20(32):11131–41. PubMed PMID: 25170200. Pubmed Central PMCID: PMC4145754. Epub 2014/08/30.PubMedPubMedCentralCrossRefGoogle Scholar
  186. 186.
    Lautt WW. The 1995 Ciba-Geigy Award Lecture. Intrinsic regulation of hepatic blood flow. Can J Physiol Pharmacol. 1996;74(3):223–33. PubMed PMID: 8773400. Epub 1996/03/01.PubMedCrossRefPubMedCentralGoogle Scholar
  187. 187.
    Jin WX, Wang B, Zhang YL, et al. Effects of hepatic blood inflow on liver ultrastructure and regeneration after extensive liver resection in rats with cirrhosis. Exp Ther Med. 2018;16(3):2573–83. PubMed PMID: 30210605. Pubmed Central PMCID: PMC6122590. Epub 2018/09/14.PubMedPubMedCentralGoogle Scholar
  188. 188.
    Kim PTW, Klintmalm GB. J Hepatol Gastroint Dis 2016, 2:2
  189. 189.
    Kim PTW, Klintmalm GB. J Hepatol Gastroint Dis. 2016;2(2)
  190. 190.
    Smyrniotis V, Kostopanagiotou G, Kondi A, et al. Hemodynamic interaction between portal vein and hepatic artery flow in small-for-size split liver transplantation. Transpl Int. 2002;15(7):355–60. PubMed PMID: 12122512. Epub 2002/07/18.PubMedCrossRefPubMedCentralGoogle Scholar
  191. 191.
    Aoki T, Imamura H, Kaneko J, et al. Intraoperative direct measurement of hepatic arterial buffer response in patients with or without cirrhosis. Liver Transpl. 2005;11(6):684–91. PubMed PMID: 15915492. Epub 2005/05/26.PubMedCrossRefPubMedCentralGoogle Scholar
  192. 192.
    Akamatsu N, Sugawara Y, Satou S, et al. Hemodynamic changes in the hepatic circulation after the modulation of the splenic circulation in an in vivo human experimental model. Liver Transpl. 2014;20(1):116–21. PubMed PMID: 24123877. Epub 2013/10/15.PubMedCrossRefPubMedCentralGoogle Scholar
  193. 193.
    Saad WE. Nonocclusive hepatic artery hypoperfusion syndrome (splenic steal syndrome) in liver transplant recipients. Semin Intervent Radiol. 2012;29(2):140–6. PubMed PMID: 23729985. Pubmed Central PMCID: PMC3444879. Epub 2013/06/05.PubMedPubMedCentralCrossRefGoogle Scholar
  194. 194.
    Iranpour P, Lall C, Houshyar R, et al. Altered Doppler flow patterns in cirrhosis patients: an overview. Ultrasonography. 2016;35(1):3–12. PubMed PMID: 26169079. Pubmed Central PMCID: PMC4701371. Epub 2015/07/15.PubMedCrossRefPubMedCentralGoogle Scholar
  195. 195.
    Chang PD, Rajeswaran S, Nikolaidis P, et al. Cirrhotic right and left portal veins: how slow do they go? Identification of threshold velocities associated with subsequent development of hepatofugal flow. Ultrasound Q. 2013;29(2):131–5. PubMed PMID: 23698619. Epub 2013/05/24.PubMedCrossRefPubMedCentralGoogle Scholar
  196. 196.
    Kelly DM, Zhu X, Shiba H, et al. Adenosine restores the hepatic artery buffer response and improves survival in a porcine model of small-for-size syndrome. Liver Transpl. 2009;15(11):1448–57. PubMed PMID: 19877203. Epub 2009/10/31.PubMedCrossRefPubMedCentralGoogle Scholar
  197. 197.
    Bolognesi M, Sacerdoti D, Bombonato G, et al. Change in portal flow after liver transplantation: effect on hepatic arterial resistance indices and role of spleen size. Hepatology. 2002;35(3):601–8. PubMed PMID: 11870373. Epub 2002/03/01.PubMedCrossRefPubMedCentralGoogle Scholar
  198. 198.
    Bosch J, Pizcueta P, Feu F, et al. Pathophysiology of portal hypertension. Gastroenterol Clin North Am. 1992;21(1):1–14. PubMed PMID: 1568769. Epub 1992/03/01.PubMedPubMedCentralGoogle Scholar
  199. 199.
    Abdelaziz O, Emad-Eldin S, Hussein A, Osman AMA. Role of Doppler ultrasonography in defining normal and abnormal graft hemodynamics after living-donor liver transplant. Exp Clin Transplant. 2017;15(3):306–13. PubMed PMID: 27819194. Epub 2016/11/08.PubMedPubMedCentralGoogle Scholar
  200. 200.
    Al-Hamoudi WK. Hemodynamics in the immediate post-transplantation period in alcoholic and viral cirrhosis. World J Gastroenterol. 2010;16(5):608–12.PubMedPubMedCentralCrossRefGoogle Scholar
  201. 201.
    Spitzer AL, Dick AA, Bakthavatsalam R, et al. Intraoperative portal vein blood flow predicts allograft and patient survival following liver transplantation. HPB (Oxford). 2010;12(3):166–73. PubMed PMID: 20590883. Pubmed Central PMCID: PMC2889268. Epub 2010/07/02.CrossRefGoogle Scholar
  202. 202.
    Gupta A, Klintmalm GB, Kim PT. Ligating coronary vein varices: an effective treatment of “coronary vein steal” to increase portal flow in liver transplantation. Liver Transpl. 2016;22(7):1037–9. PubMed PMID: 27028766. Epub 2016/03/31.PubMedCrossRefPubMedCentralGoogle Scholar
  203. 203.
    Dalal A. Anesthesia for liver transplantation. Transplant Rev (Orlando). 2016;30(1):51–60. PubMed PMID: 26118926. Epub 2015/06/30.CrossRefGoogle Scholar
  204. 204.
    Molmenti EP, Levy MF, Molmenti H, et al. Correlation between intraoperative blood flows and hepatic artery strictures in liver transplantation. Liver Transpl. 2002;8(2):160–3. PubMed PMID: 11862593. Epub 2002/02/28.PubMedCrossRefPubMedCentralGoogle Scholar
  205. 205.
    Kim PT, Saracino G, Jennings L, et al. Ratio of hepatic arterial flow to recipient body weight predicts biliary complications after deceased donor liver transplantation. HPB (Oxford). 2014;16(12):1083–7. PubMed PMID: 25041738. Pubmed Central PMCID: PMC4253331. Epub 2014/07/22.CrossRefGoogle Scholar
  206. 206.
    Bonnel AR, Bunchorntavakul C, Rajender Reddy K. Transjugular intrahepatic portosystemic shunts in liver transplant recipients. Liver Transpl. 2014;20(2):130–9. PubMed PMID: 24142390. Epub 2013/10/22.PubMedCrossRefPubMedCentralGoogle Scholar
  207. 207.
    Fagiuoli S, Bruno R, Debernardi Venon W, et al. Consensus conference on TIPS management: techniques, indications, contraindications. Dig Liver Dis. 2017;49(2):121–37. PubMed PMID: 27884494. Epub 2016/11/26.PubMedPubMedCentralCrossRefGoogle Scholar
  208. 208.
    Tripathi D, Therapondos G, Redhead DN, et al. Transjugular intrahepatic portosystemic stent-shunt and its effects on orthotopic liver transplantation. Eur J Gastroenterol Hepatol. 2002;14(8):827–32. PubMed PMID: 12172401. Epub 2002/08/13.PubMedCrossRefPubMedCentralGoogle Scholar
  209. 209.
    Awad N, Horrow MM, Parsikia A, et al. Perioperative management of spontaneous splenorenal shunts in orthotopic liver transplant patients. Exp Clin Transplant. 2012;10(5):475–81. PubMed PMID: 22891944. Epub 2012/08/16.PubMedCrossRefPubMedCentralGoogle Scholar
  210. 210.
    Dua A, McElroy L, Wochinski A, et al. Portal steal syndrome after full-size deceased donor liver transplantation. WMJ. 2016;115(3):147–50. PubMed PMID: 27443092. Epub 2016/07/23.PubMedPubMedCentralGoogle Scholar
  211. 211.
    Lee SG, Moon DB, Ahn CS, et al. Ligation of left renal vein for large spontaneous splenorenal shunt to prevent portal flow steal in adult living donor liver transplantation. Transpl Int. 2007;20(1):45–50. PubMed PMID: 17181652. Epub 2006/12/22.PubMedCrossRefPubMedCentralGoogle Scholar
  212. 212.
    Kim B, Kim KW, Song GW, Lee SG. Portal flow steal after liver transplantation. Clin Mol Hepatol. 2015;21(3):314–7. PubMed PMID: 26523275. Pubmed Central PMCID: PMC4612294. Epub 2015/11/03.PubMedPubMedCentralCrossRefGoogle Scholar
  213. 213.
    Wu TJ, Dahiya D, Lee CS, et al. Impact of portal venous hemodynamics on indices of liver function and graft regeneration after right lobe living donor liver transplantation. Liver Transpl. 2011;17(9):1035–45. PubMed PMID: 21542130. Epub 2011/05/05.PubMedPubMedCentralGoogle Scholar
  214. 214.
    Castillo-Suescun F, Oniscu GC, Hidalgo E. Hemodynamic consequences of spontaneous splenorenal shunts in deceased donor liver transplantation. Liver Transpl. 2011;17(8):891–5. PubMed PMID: 21425432. Epub 2011/03/23.PubMedCrossRefPubMedCentralGoogle Scholar
  215. 215.
    Tang R, Han D, Li M, et al. Left renal vein ligation for large splenorenal shunt during liver transplantation. ANZ J Surg. 2017;87(10):767–72. PubMed PMID: 28851020. Epub 2017/08/30.PubMedCrossRefPubMedCentralGoogle Scholar
  216. 216.
    Kim H, Yoon KC, Lee KW, et al. Tips and pitfalls in direct ligation of large spontaneous splenorenal shunt during liver transplantation. Liver Transpl. 2017;23(7):899–906. PubMed PMID: 28481004. Epub 2017/05/10.PubMedCrossRefPubMedCentralGoogle Scholar
  217. 217.
    Trotter JF. Challenges in living donor liver transplantation. Clin Liver Dis. 2014;18(3):651–60. PubMed PMID: 25017081. Epub 2014/07/16.PubMedCrossRefPubMedCentralGoogle Scholar
  218. 218.
    Graham JA, Samstein B, Emond JC. Early graft dysfunction in living donor liver transplantation and the small for size syndrome. Curr Transplant Rep. 2014;1(1):43–52. PubMed PMID: 27280080. Pubmed Central PMCID: PMC4893794. Epub 2014/03/01.PubMedPubMedCentralCrossRefGoogle Scholar
  219. 219.
    Miller CM, Quintini C, Dhawan A, et al. The international liver transplantation society living donor liver transplant recipient guideline. Transplantation. 2017;101(5):938–44. PubMed PMID: 28437386. Pubmed Central PMCID: PMC5642345. Epub 2017/04/25.PubMedCrossRefPubMedCentralGoogle Scholar
  220. 220.
    Muzaale AD, Dagher NN, Montgomery RA, et al. Estimates of early death, acute liver failure, and long-term mortality among live liver donors. Gastroenterology. 2012;142(2):273–80. PubMed PMID: 22108193. Epub 2011/11/24.PubMedCrossRefPubMedCentralGoogle Scholar
  221. 221.
    Abecassis MM, Fisher RA, Olthoff KM, et al. Complications of living donor hepatic lobectomy – a comprehensive report. Am J Transplant. 2012;12(5):1208–17. PubMed PMID: 22335782. Pubmed Central PMCID: PMC3732171. Epub 2012/02/18.PubMedPubMedCentralCrossRefGoogle Scholar
  222. 222.
    Lo CM. Complications and long-term outcome of living liver donors: a survey of 1,508 cases in five Asian centers. Transplantation. 2003;75(3 Suppl):S12–5. PubMed PMID: 12589131. Epub 2003/02/18.PubMedCrossRefPubMedCentralGoogle Scholar
  223. 223.
    Hashikura Y, Ichida T, Umeshita K, et al. Donor complications associated with living donor liver transplantation in Japan. Transplantation. 2009;88(1):110–4. PubMed PMID: 19584689. Epub 2009/07/09.PubMedCrossRefPubMedCentralGoogle Scholar
  224. 224.
    Soejima Y, Shirabe K, Taketomi A, et al. Left lobe living donor liver transplantation in adults. Am J Transplant. 2012;12(7):1877–85. PubMed PMID: 22429497. Epub 2012/03/21.PubMedCrossRefPubMedCentralGoogle Scholar
  225. 225.
    Levy GA, Selzner N, Grant DR. Fostering liver living donor liver transplantation. Curr Opin Organ Transplant. 2016;21(2):224–30. PubMed PMID: 26867047. Epub 2016/02/13.PubMedCrossRefPubMedCentralGoogle Scholar
  226. 226.
    Navasa M, Feu F, Garcia-Pagan JC, et al. Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology. 1993;17(3):355–60. PubMed PMID: 8444409. Epub 1993/03/01.PubMedCrossRefPubMedCentralGoogle Scholar
  227. 227.
    Kelly DM, Demetris AJ, Fung JJ, et al. Porcine partial liver transplantation: a novel model of the "small-for-size" liver graft. Liver Transpl. 2004;10(2):253–63. PubMed PMID: 14762864. Epub 2004/02/06.PubMedCrossRefPubMedCentralGoogle Scholar
  228. 228.
    Demetris AJ, Kelly DM, Eghtesad B, et al. Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol. 2006;30(8):986–93. PubMed PMID: 16861970. Epub 2006/07/25.PubMedCrossRefPubMedCentralGoogle Scholar
  229. 229.
    Tucker ON, Heaton N. The ‘small for size’ liver syndrome. Curr Opin Crit Care. 2005;11(2):150–5. PubMed PMID: 15758596. Epub 2005/03/11.PubMedCrossRefPubMedCentralGoogle Scholar
  230. 230.
    Herold K, Moser B, Chen Y, et al. Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress. J Leukoc Biol. 2007;82(2):204–12. PubMed PMID: 17513693. Epub 2007/05/22.PubMedCrossRefPubMedCentralGoogle Scholar
  231. 231.
    Soin AS. Smoothing the path: reducing biliary complications, addressing small-for-size syndrome, and making other adaptations to decrease the risk for living donor liver transplant recipients. Liver Transpl. 2012;18(Suppl 2):S20–4. PubMed PMID: 22927168. Epub 2012/08/29.PubMedCrossRefPubMedCentralGoogle Scholar
  232. 232.
    Dahm F, Georgiev P, Clavien PA. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant. 2005;5(11):2605–10. PubMed PMID: 16212618. Epub 2005/10/11.PubMedCrossRefPubMedCentralGoogle Scholar
  233. 233.
    Selzner M, Kashfi A, Cattral MS, et al. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation. Liver Transpl. 2009;15(12):1776–82. PubMed PMID: 19938139. Epub 2009/11/26.PubMedCrossRefPubMedCentralGoogle Scholar
  234. 234.
    Kaido T, Mori A, Ogura Y, et al. Lower limit of the graft-to-recipient weight ratio can be safely reduced to 0.6% in adult-to-adult living donor liver transplantation in combination with portal pressure control. Transplant Proc. 2011;43(6):2391–3. PubMed PMID: 21839274. Epub 2011/08/16.PubMedCrossRefPubMedCentralGoogle Scholar
  235. 235.
    Ben-Haim M, Emre S, Fishbein TM, et al. Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient's disease. Liver Transpl. 2001;7(11):948–53. PubMed PMID: 11699030. Epub 2001/11/08.PubMedCrossRefPubMedCentralGoogle Scholar
  236. 236.
    Ogura Y, Hori T, El Moghazy WM, et al. Portal pressure <15 mm Hg is a key for successful adult living donor liver transplantation utilizing smaller grafts than before. Liver Transpl. 2010;16(6):718–28. PubMed PMID: 20517905. Epub 2010/06/03PubMedPubMedCentralGoogle Scholar
  237. 237.
    Sainz-Barriga M, Scudeller L, Costa MG, et al. Lack of a correlation between portal vein flow and pressure: toward a shared interpretation of hemodynamic stress governing inflow modulation in liver transplantation. Liver Transpl. 2011;17(7):836–48. PubMed PMID: 21384528. Epub 2011/03/09.PubMedCrossRefPubMedCentralGoogle Scholar
  238. 238.
    Hessheimer AJ, Fondevila C, Taura P, et al. Decompression of the portal bed and twice-baseline portal inflow are necessary for the functional recovery of a “small-for-size” graft. Ann Surg. 2011;253(6):1201–10. PubMed PMID: 21587116. Epub 2011/05/19.PubMedCrossRefPubMedCentralGoogle Scholar
  239. 239.
    Shimamura T, Taniguchi M, Jin MB, et al. Excessive portal venous inflow as a cause of allograft dysfunction in small-for-size living donor liver transplantation. Transplant Proc. 2001;33(1–2):1331. PubMed PMID: 11267312. Epub 2001/03/27.PubMedCrossRefPubMedCentralGoogle Scholar
  240. 240.
    Troisi R, Cammu G, Militerno G, et al. Modulation of portal graft inflow: a necessity in adult living-donor liver transplantation? Ann Surg. 2003;237(3):429–36. PubMed PMID: 12616129. Pubmed Central PMCID: PMC1514313. Epub 2003/03/05.PubMedPubMedCentralGoogle Scholar
  241. 241.
    Troisi RI, Berardi G, Tomassini F, Sainz-Barriga M. Graft inflow modulation in adult-to-adult living donor liver transplantation: a systematic review. Transplant Rev (Orlando). 2017;31(2):127–35. PubMed PMID: 27989547. Epub 2016/12/19.CrossRefGoogle Scholar
  242. 242.
    Ito T, Kiuchi T, Yamamoto H, et al. Changes in portal venous pressure in the early phase after living donor liver transplantation: pathogenesis and clinical implications. Transplantation. 2003;75(8):1313–7. PubMed PMID: 12717222. Epub 2003/04/30.PubMedCrossRefPubMedCentralGoogle Scholar
  243. 243.
    Sato Y, Yamamoto S, Oya H, et al. Splenectomy for reduction of excessive portal hypertension after adult living-related donor liver transplantation. Hepato-Gastroenterology. 2002;49(48):1652–5. PubMed PMID: 12397756. Epub 2002/10/26.PubMedPubMedCentralGoogle Scholar
  244. 244.
    Umeda Y, Yagi T, Sadamori H, et al. Effects of prophylactic splenic artery modulation on portal overperfusion and liver regeneration in small-for-size graft. Transplantation. 2008;86(5):673–80. PubMed PMID: 18791439. Epub 2008/09/16.PubMedCrossRefPubMedCentralGoogle Scholar
  245. 245.
    Troisi R, Ricciardi S, Smeets P, et al. Effects of hemi-portocaval shunts for inflow modulation on the outcome of small-for-size grafts in living donor liver transplantation. Am J Transplant. 2005;5(6):1397–404. PubMed PMID: 15888047. Epub 2005/05/13.PubMedCrossRefPubMedCentralGoogle Scholar
  246. 246.
    Selzner M, Kashfi A, Cattral MS, et al. Live donor liver transplantation in high MELD score recipients. Ann Surg. 2010;251(1):153–7. PubMed PMID: 19858705. Epub 2009/10/28.PubMedCrossRefPubMedCentralGoogle Scholar
  247. 247.
    Hoehn RS, Wilson GC, Wima K, et al. Comparing living donor and deceased donor liver transplantation: a matched national analysis from 2007 to 2012. Liver Transpl. 2014;20(11):1347–55. PubMed PMID: 25044564. Epub 2014/07/22.PubMedCrossRefPubMedCentralGoogle Scholar
  248. 248.
    Olthoff KM, Merion RM, Ghobrial RM, et al. Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg. 2005;242(3):314–23; discussion 23–5. PubMed PMID: 16135918. Pubmed Central PMCID: PMC1357740. Epub 2005/09/02.PubMedPubMedCentralGoogle Scholar
  249. 249.
    Olthoff KM, Smith AR, Abecassis M, et al. Defining long-term outcomes with living donor liver transplantation in North America. Ann Surg. 2015;262(3):465–75; discussion 73–5. PubMed PMID: 26258315. Pubmed Central PMCID: PMC4545521. Epub 2015/08/11.PubMedPubMedCentralCrossRefGoogle Scholar
  250. 250.
    Pruett TL, Tibell A, Alabdulkareem A, et al. The ethics statement of the Vancouver Forum on the live lung, liver, pancreas, and intestine donor. Transplantation. 2006;81(10):1386–7. PubMed PMID: 16732173. Epub 2006/05/30.PubMedCrossRefPubMedCentralGoogle Scholar
  251. 251.
    Li C, Wen TF, Yan LN, et al. Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation. Ann Hepatol. 2012;11(4):471–7. PubMed PMID: 22700628. Epub 2012/06/16.PubMedCrossRefPubMedCentralGoogle Scholar
  252. 252.
    Perumpail RB, Yoo ER, Cholankeril G, et al. Underutilization of living donor liver transplantation in the United States: Bias against MELD 20 and higher. J Clin Transl Hepatol. 2016;4(3):169–74. PubMed PMID: 27777886. Pubmed Central PMCID: PMC5075001. Epub 2016/10/26.PubMedPubMedCentralCrossRefGoogle Scholar
  253. 253.
    Feng S. Living donor liver transplantation in high model for end-stage liver disease score patients. Liver Transpl. 2017;23(S1):S9–S21. PubMed PMID: 28719072. Epub 2017/07/19.PubMedCrossRefPubMedCentralGoogle Scholar
  254. 254.
    Kaido T, Tomiyama K, Ogawa K, et al. Section 12. Living donor liver transplantation for patients with high model for end-stage liver disease scores and acute liver failure. Transplantation. 2014;97(Suppl 8):S46–7. PubMed PMID: 24849834. Epub 2014/05/23.PubMedCrossRefPubMedCentralGoogle Scholar
  255. 255.
    Liu CL, Fan ST, Lo CM, et al. Live-donor liver transplantation for acute-on-chronic hepatitis B liver failure. Transplantation. 2003;76(8):1174–9. PubMed PMID: 14578749. Epub 2003/10/28.PubMedCrossRefGoogle Scholar
  256. 256.
    Chok K, Chan SC, Fung JY, et al. Survival outcomes of right-lobe living donor liver transplantation for patients with high model for end-stage liver disease scores. Hepatobiliary Pancreat Dis Int. 2013;12(3):256–62. PubMed PMID: 23742770. Epub 2013/06/08.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Michael Sean Bleszynski
    • 1
    • 2
  • Peter T. W. Kim
    • 1
  1. 1.University of British ColumbiaVancouverCanada
  2. 2.Vancouver General Hospital, Department of General SurgeryVancouverCanada

Personalised recommendations